Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Diel · SciRah

Researcher profile · Semantic Scholar

I. Diel

Share profile

I. Diel — researcher profile on SciRah

h-index: 43
Works: 185
Citations: 8,004

Most-cited papers

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.
F. Saad, Janet E. Brown, C. Poznak, T. Ibrahim +14 more
2012Annals of Oncology643 citations Open access
Semantic Scholar
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies
J. Body, I. Diel, M. Lichinitzer, A. Lazarev +4 more
2004British Journal of Cancer328 citations Open access
Semantic Scholar
Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up.
I. Diel, A. Jaschke, E. Solomayer, C. Gollan +3 more
2008Annals of Oncology231 citations Open access
Semantic Scholar
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
P. Hadji, R. Coleman, C. Wilson, T. Powles +24 more
2016Annals of Oncology195 citations Open access
Semantic Scholar
Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer
J. Body, I. Diel, R. Bell, M. Pecherstorfer +4 more
2004Pain191 citations
Semantic Scholar
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
A. Stopeck, K. Fizazi, J. Body, Janet E. Brown +15 more
2015Supportive Care in Cancer182 citations Open access
Semantic Scholar
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.
I. Diel, J. Body, M. Lichinitser, E. Kreuser +4 more
2004European Journal of Cancer169 citations
Semantic Scholar
Adverse effects of bisphosphonates: current issues.
I. Diel, R. Bergner, K. Grötz
2007The Journal of Supportive Oncology165 citations
Semantic Scholar
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.
F. Saad, J. E. Brown, C. V. Van Poznak, T. Ibrahim +14 more
2012138 citations Open access
Semantic Scholar
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid
Miguel Martín, R. Bell, H. Bourgeois, A. Brufsky +15 more
2012Clinical Cancer Research134 citations Open access
Semantic Scholar
Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin
C. Maihöfner, I. Diel, H. Tesch, Tamara Quandel +1 more
2021Supportive Care in Cancer129 citations Open access
Semantic Scholar
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).
M. Untch, B. Gerber, N. Harbeck, C. Jackisch +27 more
2013Breast Care125 citations Open access
Semantic Scholar
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
I. Diel, I. Fogelman, B. Al-Nawas, B. Hoffmeister +6 more
2007Critical reviews in oncology/hematology102 citations
Semantic Scholar
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
G. von Minckwitz, V. Möbus, A. Schneeweiss, J. Huober +19 more
2013Journal of Clinical Oncology99 citations
Semantic Scholar
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019
N. Ditsch, M. Untch, M. Thill, V. Müller +41 more
2019Breast Care82 citations Open access
Semantic Scholar
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020.
N. Ditsch, M. Untch, C. Kolberg-Liedtke, C. Jackisch +42 more
2020Breast Care78 citations Open access
Semantic Scholar
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts
C. Jackisch, N. Harbeck, J. Huober, G. von Minckwitz +21 more
2015Breast Care59 citations Open access
Semantic Scholar
Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
F. Schuetz, I. Diel, M. Pueschel, T. von Holst +5 more
2007American Journal of Obstetrics and Gynecology54 citations
Semantic Scholar
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019
M. Thill, C. Jackisch, W. Janni, V. Müller +41 more
2019Breast Care52 citations Open access
Semantic Scholar
Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment.
C. Jehn, I. Diel, F. Overkamp, A. Kurth +3 more
2016Anticancer Research52 citations
Semantic Scholar
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.
I. Diel, J. Body, A. Stopeck, S. Vadhan-Raj +6 more
2015European Journal of Cancer47 citations
Semantic Scholar
Differences in Nephrotoxicity of Intravenous Bisphosphonates for the Treatment of Malignancy- Related Bone Disease
R. Bergner, I. Diel, D. Henrich, M. Hoffmann +1 more
2006Oncology Research and Treatment47 citations
Semantic Scholar
Early identification and intervention matters: A comprehensive review of current evidence and recommendations for the monitoring of bone health in patients with cancer.
T. Brodowicz, P. Hadji, D. Niepel, I. Diel
2017Cancer Treatment Reviews41 citations Open access
Semantic Scholar
Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review
I. Diel, R. Weide, H. Köppler, L. Antràs +5 more
2009Supportive Care in Cancer40 citations
Semantic Scholar
Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results.
J. Body, I. Diel, D. Tripathy, B. Bergström
2006European Journal of Cancer Care39 citations Open access
Semantic Scholar
Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a review
I. Diel
2007Supportive Care in Cancer36 citations
Semantic Scholar
Profiling the safety and tolerability of bisphosphonates.
J. Body, I. Diel, R. Bell
2004Seminars in Oncology36 citations
Semantic Scholar
Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast Cancer
R. Souchon, P. Feyer, C. Thomssen, T. Fehm +5 more
2010Breast Care35 citations Open access
Semantic Scholar
Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
I. Diel, S. Ansorge, D. Hohmann, C. Giannopoulou +2 more
2020Supportive Care in Cancer29 citations Open access
Semantic Scholar
Prognostic Value of Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: A Long-term Follow-up Study
C. Domschke, I. Diel, S. Englert, S. Kalteisen +5 more
2013Annals of Surgical Oncology29 citations
Semantic Scholar
Adjuvant clodronate treatment improves the overall survival of primary breast cancer patients with micrometastases to bone marrow - a longtime follow-up
A. Jaschke, G. Bastert, E. Solomayer, S. Costa +2 more
200428 citations
Semantic Scholar
Ibandronate: its role in metastatic breast cancer.
D. Cameron, M. Fallon, I. Diel
2006The Oncologist26 citations Open access
Semantic Scholar
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.
M. Beckmann, Frederik A. Stübs, M. Koch, P. Mallmann +62 more
2022Geburtshilfe und Frauenheilkunde25 citations Open access
Semantic Scholar
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus
M. Untch, N. Harbeck, J. Huober, G. von Minckwitz +21 more
2015Geburtshilfe und Frauenheilkunde25 citations Open access
Semantic Scholar
Long-Term Safety of Intravenous Ibandronic Acid for Up to 4 Years in Metastatic Breast Cancer
M. Pecherstorfer, S. Rivkin, J. Body, I. Diel +1 more
2006Clinical drug investigation25 citations
Semantic Scholar
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany
H. Link, I. Diel, C. Ohlmann, L. Holtmann +1 more
2019Supportive Care in Cancer24 citations Open access
Semantic Scholar
S2-4: GAIN Study: A Phase III Trial To Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients with Node-Positive Primary Breast Cancer – 1st Interim Efficacy Analysis.
V. Möbus, I. Diel, N. Harbeck, D. Elling +13 more
201123 citations
Semantic Scholar
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.
T. Fehm, Frederik A. Stübs, M. Koch, P. Mallmann +61 more
2022Geburtshilfe und Frauenheilkunde19 citations Open access
Semantic Scholar
Rapid administration of ibandronate does not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancy
M. Pecherstorfer, I. Diel
2004Supportive Care in Cancer19 citations
Semantic Scholar
Ibandronate reduces skeletal morbidity in patients with breast cancer.
D. Tripathy, I. Diel, J. Body
2004Seminars in Oncology18 citations
Semantic Scholar
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors
C. Abboud, Nicole Lang, H. Fung, A. Lammerich +7 more
2018Supportive Care in Cancer17 citations
Semantic Scholar
NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis
C. Kurbacher, T. Fietz, I. Diel, Matthias Egert +17 more
2015Oncology Research and Treatment16 citations Open access
Semantic Scholar
Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment
S. Stefanovic, I. Diel, P. Sinn, S. Englert +12 more
2016Annals of Surgical Oncology14 citations
Semantic Scholar
Bone pain reduction in patients with metastatic breast cancer treated with ibandronate–results from a post-marketing surveillance study
I. Diel, A. Kurth, H. Sittig, H. Meden +3 more
2010Supportive Care in Cancer14 citations
Semantic Scholar
Bisphosphonates in Breast Cancer Patients with Bone Metastases
I. Diel
2010Breast Care14 citations Open access
Semantic Scholar
Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma
Janet E. Brown, C. Barrios, I. Diel, T. Facon +12 more
201113 citations
Semantic Scholar
Influence of fluor salts, hormone replacement therapy and calcitonin on the concentration of insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor-beta 1 in human iliac crest bone matrix from patients with primary osteoporosis.
C. Pepene, T. Seck, I. Diel, H. Minne +2 more
2004European Journal of Endocrinology13 citations Open access
Semantic Scholar
Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)
M. Untch, B. Gerber, V. Möbus, A. Schneeweiss +24 more
2011Breast Care11 citations Open access
Semantic Scholar
What do patients with metastatic bone pain need
I. Diel
200610 citations
Semantic Scholar
Renal safety of ibandronate in patients with bone metastases from breast cancer: phase III trial results
R. Bell, I. Diel, J. Body, B. Bergström
20048 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Body×10
Invite
J. Body — researcher profile on SciRah
N. Harbeck×10
Invite
N. Harbeck — researcher profile on SciRah
M. Untch×10
Invite
M. Untch — researcher profile on SciRah
A. Schneeweiss×10
Invite
A. Schneeweiss — researcher profile on SciRah

×10

Invite

C. Thomssen — researcher profile on SciRah

Invite

C. Jackisch — researcher profile on SciRah

Invite

T. Fehm — researcher profile on SciRah

Invite

V. Möbus — researcher profile on SciRah

Invite

W. Janni — researcher profile on SciRah

Invite

S. Loibl — researcher profile on SciRah

Invite

J. Blohmer — researcher profile on SciRah

Invite

J. Huober — researcher profile on SciRah